COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

3TMPO (Triple-Tracer Strategy Against Metastatic Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04000776
Recruitment Status : Recruiting
First Posted : June 27, 2019
Last Update Posted : February 11, 2020
Fonds de la Recherche en Santé du Québec
Canadian Cancer Society Research Institute (CCSRI)
Merck Canada Inc.
Information provided by (Responsible Party):
Université de Sherbrooke

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 2021
Estimated Study Completion Date : September 2021